TY - JOUR
T1 - Phage-targeting bimetallic nanoplasmonic biochip functionalized with bacterial outer membranes as a biorecognition element
AU - Kim, Moon Ju
AU - Bae, Hyung Eun
AU - Kwon, Soonil
AU - Park, Mi Kyung
AU - Yong, Dongeun
AU - Kang, Min Jung
AU - Pyun, Jae Chul
N1 - Publisher Copyright:
© 2023
PY - 2023/10/15
Y1 - 2023/10/15
N2 - The use of phages—a natural predator of bacteria—has emerged as a therapeutic strategy for treating multidrug-resistant bacterial infections; thus, the isolation and detection of phages from the environment is crucial for advancing phage therapy. Herein, for the first time, we propose a nanoplasmonic-based biodetection platform for phages that utilizes bacterial outer membranes (OMs) as a biorecognition element. Conventional biosensors based on phage-bacteria interactions encounter multiple challenges due to the bacteriolytic phages and potentially toxic bacteria, resulting in instability and risk in the measurement. Therefore, instead of whole living bacteria, we employ a safe biochemical OMs fraction presenting phage-specific receptors, allowing the robust and reliable phage detection. In addition, the biochip is constructed on bimetallic nanoplasmonic islands through solid-state dewetting for synergy between Au and Ag, whereby sensitive detection of phage-OMs interactions is achieved by monitoring the absorption peak shift. For high detection performance, the nanoplasmonic chip is optimized by systematically investigating the morphological features, e.g., size and packing density of the nanoislands. Using our optimized device, phages are detected with high sensitivity (≥∼104 plaques), specificity (little cross-reactivity), and affinity (stronger binding to the host OMs than anti-bacterial antibodies), further exhibiting the cell-killing activities.
AB - The use of phages—a natural predator of bacteria—has emerged as a therapeutic strategy for treating multidrug-resistant bacterial infections; thus, the isolation and detection of phages from the environment is crucial for advancing phage therapy. Herein, for the first time, we propose a nanoplasmonic-based biodetection platform for phages that utilizes bacterial outer membranes (OMs) as a biorecognition element. Conventional biosensors based on phage-bacteria interactions encounter multiple challenges due to the bacteriolytic phages and potentially toxic bacteria, resulting in instability and risk in the measurement. Therefore, instead of whole living bacteria, we employ a safe biochemical OMs fraction presenting phage-specific receptors, allowing the robust and reliable phage detection. In addition, the biochip is constructed on bimetallic nanoplasmonic islands through solid-state dewetting for synergy between Au and Ag, whereby sensitive detection of phage-OMs interactions is achieved by monitoring the absorption peak shift. For high detection performance, the nanoplasmonic chip is optimized by systematically investigating the morphological features, e.g., size and packing density of the nanoislands. Using our optimized device, phages are detected with high sensitivity (≥∼104 plaques), specificity (little cross-reactivity), and affinity (stronger binding to the host OMs than anti-bacterial antibodies), further exhibiting the cell-killing activities.
KW - Anti-Bacterial antibody
KW - Bacterial outer membranes
KW - Bimetallic nanoplasmonic islands
KW - Localized surface plasmon resonance
KW - Phage-targeting biosensor
UR - http://www.scopus.com/inward/record.url?scp=85167968598&partnerID=8YFLogxK
U2 - 10.1016/j.bios.2023.115598
DO - 10.1016/j.bios.2023.115598
M3 - Article
C2 - 37597282
AN - SCOPUS:85167968598
SN - 0956-5663
VL - 238
JO - Biosensors and Bioelectronics
JF - Biosensors and Bioelectronics
M1 - 115598
ER -